AM-2201

AM-2201
Legal status

Legal status	BR: Class F2 (Prohibited psychotropics) CA: Schedule II DE: Anlage II (Authorized trade only, not prescriptible) NZ: Temporary Class UK: Class B US: Schedule I UN: Psychotropic Schedule II
Identifiers
IUPAC name 1-[(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone
CAS Number	335161-24-5^Y
PubChem CID	53393997
ChemSpider	24751884^Y
UNII	TBJ0966F1O
KEGG	C22771
CompTox Dashboard (EPA)	DTXSID50187158
Chemical and physical data
Formula	C₂₄H₂₂FNO
Molar mass	359.444 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C(C1=CN(CCCCCF)C2=C1C=CC=C2)C3=CC=CC4=C3C=CC=C4
InChI InChI=1S/C24H22FNO/c25-15-6-1-7-16-26-17-22(20-12-4-5-14-23(20)26)24(27)21-13-8-10-18-9-2-3-11-19(18)21/h2-5,8-14,17H,1,6-7,15-16H2^Y Key:ALQFAGFPQCBPED-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)

AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.